Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11234976 Methods of using pyruvate kinase activators

Patent 11234976 was granted and assigned to Agios Pharmaceuticals on February, 2022 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Agios Pharmaceuticals

Current Assignee

Agios Pharmaceuticals

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

112349760

Patent Inventor Names

Lenny Dang0

Yue Chen0

Samuel V. Agresta0

Bruce A. Silver0

Charles Kung0

Elizabeth A. Merica0

Hua Yang0

Marvin B. Cohen0

Date of Patent

February 1, 2022

Patent Application Number

157350360

Date Filed

June 10, 2016

Patent Citations

‌

US Patent 10029987 Therapeutic compounds and compositions

‌

US Patent 10632114 Pyruvate kinase activators for use in therapy

Patent Citations Received

‌

US Patent RE49582 Therapeutic compounds and compositions

Patent Primary Examiner

‌

Jeffrey S Lundgren

Patent abstract

Described herein are methods for using compounds that activate pyruvate kinase.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11234976 Methods of using pyruvate kinase activators

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API